Patent details
EP1904066
Title:
COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
Basic Information
- Publication number:
- EP1904066
- PCT Application Number:
- US2006026361
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067864967
- PCT Publication Number:
- WO2007006003
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
- French Title of Invention:
- COMBINAISONS D'ESZOPICLONE ET DE TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTALENAMINE, pour le TRAITEMENT DE LA MENOPAUSE, perimenopause ET des TROUBLES COGNITIFS
- German Title of Invention:
- KOMBINATIONEN VON ESZOPICLON UND TRANS-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALINAMIN ZUR BEHANDLUNG DER MENOPAUSE, Perimenopause UND VON KOGNITIVEN STÖRUNGEN
- SPC Number:
-
Dates
- Filing date:
- 06/07/2006
- Grant date:
- 23/05/2018
- EP Publication Date:
- 02/04/2008
- PCT Publication Date:
- 11/01/2007
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/05/2018
- EP B1 Publication Date:
- 23/05/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 06/07/2018
- Expiration date:
- 06/07/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/05/2018
-
-
- Name:
- Sunovion Pharmaceuticals Inc.
- Address:
- 84 Waterford Drive, Marlborough, MA 01752, United States (US)
Inventor
1
- Name:
- WILKINSON, H. Scott
- Address:
- United States (US)
2
- Name:
- CARON, Judy
- Address:
- United States (US)
3
- Name:
- SINGH, Surendra P.
- Address:
- United States (US)
4
- Name:
- HAN, Zhengxu
- Address:
- United States (US)
5
- Name:
- SU, Xiping
- Address:
- United States (US)
6
- Name:
- KOENIG, Stephan G.
- Address:
- United States (US)
7
- Name:
- LALJI, Karim
- Address:
- Canada (CA)
8
- Name:
- BAKALE, Roger P.
- Address:
- United States (US)
9
- Name:
- WESSEL, Thomas
- Address:
- United States (US)
10
- Name:
- VARNEY, Mark
- Address:
- United States (US)
Priority
- Priority Number:
- 697013 P
- Priority Date:
- 06/07/2005
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/135;
A61K 31/4985;
A61P 25/00;
A61P 25/24;
A61P 25/28;
C07C 211/42;
Publication
European Patent Bulletin
- Issue number:
- 201821
- Publication date:
- 23/05/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-